Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Brain Injury Program
Cholesterol Lowering Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
24-Jun-2020
Corporate Presentation for the Reach Markets Virtual Event
25-May-2020
Milestone Achieved in the Nyrada Brain Injury Program
30-Apr-2020
Nyrada Preclinical Program & Corporate Update Presentation
27-Apr-2020
Change of Director's Interest Notice - JM
22-Apr-2020
Appointment of New Chief Financial Officer
20-Apr-2020
Preclinical Program & Corporate Update Global Webinar
14-Apr-2020
Appendix 4C - March 2020 quarterly
6-Apr-2020
Nyrada Newsletter Released
16-Mar-2020
Update on Progress in Nyrada Programs
27-Feb-2020
Nyrada Inc. Corporate Presentation February 2020
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Next
